Inform Diagnostics

Name

Inform Diagnostics

Legal name

Inform Diagnostics

Website

https://informdx.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Inform Diagnostics is the largest national outpatient anatomic pathology laboratory in the United States, providing fellowship-trained subspecialty diagnostic services across breast, dermatopathology, GI, urologic, and hematopathology disciplines to referring physicians in all 50 states.

Ownership category

akta.pro rank

Headquarters

HQ city

Irving

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Anatomic Pathology Testing Services: B2B pathology diagnostic services provided to healthcare providers including clinicians, hospitals, and practices. Revenue generated through laboratory testing fees for subspecialty pathology services including breast, dermatopathology, GI, urologic, and hematopathology diagnostics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Inform Diagnostics provides subspecialty anatomic pathology diagnostic testing services to healthcare providers across all 50 states. The company's core offering includes diagnostic analysis of biopsy and tissue specimens in six subspecialty areas: breast, dermatopathology, gastrointestinal, urologic, hematopathology, and COVID-19 testing, supported by molecular diagnostics, ancillary testing, digital pathology tools, and consensus case conferencing.

Product overview

Inform Diagnostics, a Fulgent Genetics company, is a leading national subspecialty anatomic pathology laboratory providing definitive patient diagnoses. The company operates a platform-plus-services model offering core pathology services across six subspecialties (Gastrointestinal, Dermatopathology, Urologic, Hematopathology, Breast Pathology, and COVID-19 Testing) complemented by technology solutions including Digital Pathology (Paige FullFocus viewer), Collaborative Case Conferencing, and seamless LIS integration. Additional offerings include expanded Hematology/Oncology testing with FISH panels, Quality Assurance programs, and clinician resources such as Scientific Publications, Clinical Vignettes, and Patient Education materials. The company was acquired by Fulgent Genetics in 2022 and subsequently acquired Bako Diagnostics and StrataDx in 2026.

Differentiator

Problem solved

Functional benefit

Products and services

• Breast Pathology Services Subspecialty anatomic pathology services for radiologists, surgeons, and oncologists in the diagnosis and management of breast disease.
• Dermatopathology Services
• Gastrointestinal Pathology Services
• Urologic Pathology Services
• Hematopathology Services Progressive molecular and antibody-based diagnostics with advanced genetic testing for blood and cancer disorders, serving oncology and hematology specialists. Includes an expanded hematology/oncology test menu with FISH panels.
• COVID-19 Testing
• Quality Assurance Program

Quantifiable outcome

• High concordance rates verified when patients are referred to outside academic institutions
• +1 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core and flagship.

• PaigecoreTechnology or Integration · 12 May 2021Inform Diagnostics and Paige entered a collaboration to integrate digital solutions with anatomic pathology diagnostics. Inform Diagnostics launched the Paige FullFocus digital pathology viewer in its laboratories, allowing pathologists to use intuitive digital tools for AI-based cancer diagnostics.
• Fulgent GeneticsflagshipStrategic or Co-development PartnerFulgent Genetics acquired Inform Diagnostics in 2022 to add diagnostic offerings including hematopathology and anatomic pathology, while providing a highly complementary nationwide commercial infrastructure to support Fulgent's rapidly expanding genomic testing footprint.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Paige: Paige is an AI-focused digital pathology company whose FullFocus viewer is deployed at Inform Diagnostics. Comparable as a technology enabler in the same anatomic pathology workflow, though Paige sells software rather than running a competing lab services business.

Broad incumbents

• Sonic Healthcare USA: Sonic Healthcare is a global diagnostics operator with US anatomic and clinical pathology operations (including Pathology Associates and other acquired labs). Comparable as a multi-site, multi-specialty pathology network serving office-based clinicians.
• Quest Diagnostics: Quest Diagnostics is the largest US clinical laboratory with a significant anatomic pathology offering (including former AmeriPath). Comparable as a broad incumbent offering anatomic pathology nationwide, but operates across a much wider test menu and customer base than Inform Diagnostics.
• Laboratory Corporation of America (LabCorp): LabCorp operates a national clinical and anatomic pathology business (including Dianon Pathology). Comparable as a large incumbent in anatomic pathology serving physicians and health systems, though pathology is one segment of a much broader diagnostics franchise.

Direct peers

• ProPath Services: ProPath is a subspecialty anatomic pathology laboratory serving dermatologists, gastroenterologists, urologists, and other office-based physicians nationwide. Highly comparable in business model, subspecialty focus, and target clinician segments.
• PathGroup: PathGroup is one of the largest privately held anatomic and clinical pathology practices in the US, offering subspecialty pathology services across similar clinical segments. Directly comparable as a multi-specialty outpatient pathology lab serving physicians and hospitals nationwide.
• NeoGenomics: NeoGenomics specializes in oncology-focused genetic and molecular pathology testing for community practices and hospitals. Highly comparable in serving community oncologists, hematologists, and urologists with specialized cancer diagnostics and a national commercial footprint.
• ARUP Laboratories: ARUP is a national reference laboratory operated by the University of Utah that provides esoteric and subspecialty anatomic pathology services to hospitals and health systems. Comparable in subspecialty depth and academic-grade diagnostics, though with a different ownership and geographic anchor.
• Dermpath Diagnostics: Dermpath Diagnostics is a national dermatopathology-focused laboratory serving dermatologists. Directly comparable in dermatopathology volume, ancillary and molecular testing capabilities, and outreach model to dermatology practices.

Regional players

• Mayo Clinic Laboratories: Mayo Clinic Laboratories is the reference laboratory arm of Mayo Clinic, offering esoteric anatomic and clinical pathology testing nationally and internationally. Comparable in subspecialty depth and quality reputation, though it is anchored by a single academic institution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/inform_dx

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inform Diagnostics